Author Correction: SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade

Correction to: Nature https://doi.org/10.1038/s41586-025-09655-y Published online 22 October 2025

In the version of this article initially published, in Fig. 2d, the red triangle depicting vaccine administration at day 17 originally appeared at day 20; in Fig. 5o, the colours of the red and blue traces in the plot were interchanged; in Extended Data Fig. 3h,i, the red and blue colour keys (currently, blue for vaccine, red for no vaccine) were interchanged. In the Fig. 3b legend, in the text now reading “vaccine days 3, 6, 21,” 21 replaces the original “17,” and in the Fig. 3k legend, now reading “vaccine days 3, 6, 20,” 20 replaces the original “21.” In the first sentence of the Methods “Cox proportional hazards regression” section, in the text now reading “For Cox proportional hazards regression, exposures defined relative to an index date...,” “exposures defined relative to an index date” replaces the original “time-dependent variables were defined.” In the first paragraph of the Methods and in the Reporting Summary, data collection timelines have been updated to say “The data-collection cut-off was 1 September 2024 for the NSCLC and melanoma datasets and 1 January 2025 for the tissue agnostic dataset.” Finally, the Acknowledgements have been amended to include the statement that G.A. and N.C. were supported by the CPRIT Research Training Award CPRIT Training Program (RP210028). The changes have been made in the HTML and PDF versions of the article.

Explore related subjects

Discover the latest articles and news in related subjects.

Author information

Author notes
  1. These authors contributed equally: Adam J. Grippin, Christiano Marconi, Sage Copling, Nan Li

  2. These authors jointly supervised this work: Elias J. Sayour, Steven H. Lin

Authors and Affiliations

  1. Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Adam J. Grippin, Nan Li, Chen Braun, Cole Woody, Priti Gupta, Min Wang, Annette Wu, Michael K. Rooney, Benjamin R. Schrank, Yifan Wang, Yifan Ma, Enoch Chang, Ramez Kouzy, Ada Argueta, Diana Amaya, Joe Chen, Gabriel Alatrash, William Dennis, Richard Liang, Wen Jiang & Steven H. Lin

  2. Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, Gainesville, FL, USA

    Christiano Marconi, Dhruvkumar Soni, Frances Weidert, Chao Xie, Eden Goldenberg, Chong Zhao, Anna DeVries, Paul Castillo, Nagheme Thomas, Andria Doty, Hector R. Mendez-Gomez & Elias J. Sayour

  3. McGovern Medical School, Houston, TX, USA

    Sage Copling, Andrew Kim, Jordan Jafarnia & Nina Nariman

  4. Department of Enterprise Data Engineering and Analytics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

  5. Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Seong Dong Jeong & Betty Y. S. Kim

  6. Brain Tumor Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Seong Dong Jeong & Betty Y. S. Kim

  7. Department of Pediatrics, Division of Hematology-Oncology, University of Florida, Gainesville, FL, USA

    Paul Castillo & Elias J. Sayour

  8. Department of Dermatology, Baylor College of Medicine, Houston, TX, USA

  9. Department of Pathology, Stanford University, Stanford, CA, USA

  10. Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

  11. Scripps Health, San Diego, CA, USA

  12. University of North Carolina, Chapel Hill, NC, USA

  13. Department of Surgical Oncology, Division Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Julie Simon, Alicia Bea Davies & Jennifer Wargo

  14. Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Jeff Lewis, Xiong Wei, Waree Rinsurongkawong, Hai Tran, Jianjun Zhang, Don L. Gibbons & John V. Heymach

  15. Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Andrew Johns & Padmanee Sharma

  16. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Jack Lee & Ryan Sun

  17. Department of Biostatistics, The University of Florida, Gainesville, FL, USA

  18. Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

  19. James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

  20. The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Ashley Aaroe, Sanu Abraham, Lee Andrews II, Kiran K. Badami, Janna A. Baganz, Pratibha Bajwa, Gregory R. Barbosa, Hannah C. Beird, Kristy Brock, Elizabeth M. Burton, Juan Cata, Caroline Chung, Catherine Claussen, John Crommett, Michael Cutherell, Bouthaina Dabaja, Hiba Dagher, Kevin M. Daniels, Mary Domask, Giulio Draetta, Paul Edelkamp Jr, Sarah Fisher, Katy Elizabeth French, Andrew Futreal, Maria Gaeta, Myrna Godoy, Drew Goldstein, Jillian Gunther, Kate Hutcheson, David Jaffray, Jeff Jin, Teny Matthew John, Trey Kell, Mark Knafl, Rayson C. Kwan, J. Jack Lee, Jennifer Litton, Kevin W. McEnery, Mary McGuire, Benjamin Mescher, Tejo Musunuru, Mayoora Muthu, Joseph Nates, Craig S. Owen, Priyadharshini Padmakumar, Nicholas Palaskas, Jay J. Patel, Sabitha Prabhakaran, Lucas Ramsey, Vinod Ravi, Cristhiam Rojas Hernandez, Bilja Sajith, Paul A. Scheet, Stephanie Schmidt, Kenna R. Shaw, Sanjay Shete, Daniel P. Shoenthal, Lessley J. Stoltenberg, Hussein Tawbi, Anastasia Turin, Samir Unni, Benju Vicknamparampil, Max C. Weber, John Weinstein, Scott Eric Woodman, Mark C. Wozny, Carol Wu, Jia Wu, James C. Yao, Chingyi Young, Emily Yu & Steven Zatorski

  21. Ascension, St Louis, MO, USA

    Thomas A. Aloia

  22. University Health, San Antonio, TX, USA

  23. Oracle Health, Kansas City, MO, USA

  24. Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA

  25. Sir Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

  26. Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia

  1. Adam J. Grippin

    Search author on:

  2. Search author on:

  3. Search author on:

  4. Search author on:

  5. Search author on:

  6. Search author on:

  7. Search author on:

  8. Search author on:

  9. Search author on:

  10. Search author on:

  11. Search author on:

  12. Search author on:

  13. Search author on:

  14. Search author on:

  15. Search author on:

  16. Search author on:

  17. Search author on:

  18. Search author on:

  19. Search author on:

  20. Search author on:

  21. Michael K. Rooney

    Search author on:

  22. Benjamin R. Schrank

    Search author on:

  23. Search author on:

  24. Search author on:

  25. Search author on:

  26. Search author on:

  27. Search author on:

  28. Search author on:

  29. Search author on:

  30. Search author on:

  31. Search author on:

  32. Search author on:

  33. Search author on:

  34. Search author on:

  35. Search author on:

  36. Search author on:

  37. Search author on:

  38. Search author on:

  39. Search author on:

  40. Search author on:

  41. Search author on:

  42. Search author on:

  43. Search author on:

  44. Search author on:

  45. Search author on:

  46. Ara A. Vaporciyan

    Search author on:

  47. Search author on:

  48. Search author on:

  49. Search author on:

  50. Search author on:

  51. Search author on:

  52. Search author on:

  53. Search author on:

  54. Don L. Gibbons

    Search author on:

  55. Search author on:

  56. Betty Y. S. Kim

    Search author on:

  57. John V. Heymach

    Search author on:

  58. Hector R. Mendez-Gomez

    Search author on:

  59. Search author on:

  60. Elias J. Sayour

    Search author on:

  61. Steven H. Lin

    Search author on:

  • , Kiran K. Badami
  • , Janna A. Baganz
  • , Gregory R. Barbosa
  • , Hannah C. Beird
  • , Elizabeth M. Burton
  • , Kevin M. Daniels
  • , Rayson C. Kwan
  • , J. Jack Lee
  • , Kevin W. McEnery
  • , Craig S. Owen
  • , Jay J. Patel
  • , Paul A. Scheet
  • , Kenna R. Shaw
  • , Daniel P. Shoenthal
  • , Lessley J. Stoltenberg
  • , Max C. Weber
  • , Mark C. Wozny
  • , James C. Yao
  • , Thomas A. Aloia

Corresponding authors

Correspondence to Adam J. Grippin, Elias J. Sayour or Steven H. Lin.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Cite this article

Grippin, A.J., Marconi, C., Copling, S. et al. Author Correction: SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade. Nature (2026). https://doi.org/10.1038/s41586-026-10974-x

Download citation

  • Version of record

  • DOIhttps://doi.org/10.1038/s41586-026-10974-x

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Original source Author Correction: SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade

Back to home